Minnesota Institute for Minimally Invasive Surgery

Cuyuna Regional Medical Center

Gastroesophageal Reflux

Glucose Metabolism Disorders

Knee Osteoarthritis

Metabolic Diseases

Endocrine System Diseases

Diabetes Mellitus

Osteoarthritis

Type 2 Diabetes Mellitus

Omeprazole

Torax Medical

DePuy Synthes

Endogenex

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a multi-center, open-label study to assess the feasibility and preliminary safety of the Endogenex Device for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering medications.

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

Cuyuna Regional Medical Center | Minnesota Institute for Minimally Invasive Surgery

Site insights

Work at this site?

Active trials

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes (REGENT-1-US)

Trial sponsors